Bildnachweis: VC Magazin, Pixabay.
In this issue’s cover interview, Dr Andrew Cavey, CEO of ITM Isotope Technologies Munich SE, shares his views on Germany’s position as a biotech hub in the international landscape. He discusses ITM’s latest developments and outlines his vision for the coming years. Also, he offers insight into the role of Germany in advancing radiotheranostics.
In addition, we explore Germany’s top biotech clusters and lesser-known life sciences regions – and shine a spotlight on the promising start-up neoplas med GmbH, based in Greifswald!
Represented in the issue: WITENO GmbH Wissenschafts + Technologiepark Nord°Ost°, BioM Biotech Cluster Development GmbH, Boston Consulting Group (BCG), Technologiepark Heidelberg GmbH, BIO Deutschland e. V., EY, leap:up GmbH, Bioscience Valuation, Life Science Factory, Avocet Bio GmbH, IZB – Innovation and Start-up Center Biotechnology and many more!
Find full access to the issue here!
Next up: Special issue „Life Sciences“ – out 25th of July! Stay tuned!
